Publication of the provisional notice of the end result of Actelion tender offer
April 24, 2017 01:00 ET
|
Actelion Pharmaceuticals Ltd
Transaction remains on track to close towards the end of the second quarter of 2017 ALLSCHWIL, SWITZERLAND - 24 April 2017 - Actelion Ltd (SIX: ATLN) today announced that Janssen Holding GmbH, a...
Publication of the provisional notice of the end result of Actelion tender offer
April 24, 2017 01:00 ET
|
Actelion Pharmaceuticals Ltd
Transaction remains on track to close towards the end of the second quarter of 2017 ALLSCHWIL, SWITZERLAND - 24 April 2017 - Actelion Ltd (SIX: ATLN) today announced that Janssen Holding GmbH, a...
Actelion amends its financial reporting schedule
April 10, 2017 11:35 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL, SWITZERLAND - 10 April 2017 - Actelion Ltd (SIX: ATLN) announced today that it has amended its reporting schedule by discontinuing the reporting of first quarter and third quarter financial...
Actelion ändert Finanzberichterstattung
April 10, 2017 11:35 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL, SCHWEIZ - 10. April 2017 - Actelion (SIX: ATLN) gab heute einen veränderten Finanzberichtsturnus bekannt. Die Berichterstattung für die Ergebnisse des ersten und dritten Quartals wird mit...
Ordentliche Generalversammlung 2017 von Actelion
April 05, 2017 06:36 ET
|
Actelion Pharmaceuticals Ltd
Aktionäre genehmigen Abspaltung des Forschungs- (Drug Discovery) und frühklinischen Produktkandidatengeschäfts (Early-Stage Pipeline) von Actelion zur Gründung des neuen Unternehmens Idorsia Ltd ...
Actelion's Annual General Meeting of Shareholders 2017
April 05, 2017 06:36 ET
|
Actelion Pharmaceuticals Ltd
Shareholders approve demerger of Actelion's drug discovery and early clinical pipeline to form new company Idorsia Strategic transaction with Johnson & Johnson on track to complete in the second...
Johnson & Johnson publishes interim result for Actelion tender offer and declares the tender offer successful
March 31, 2017 01:01 ET
|
Actelion Pharmaceuticals Ltd
Announces update on regulatory approvalsTransaction remains on track to close in the second quarter of 2017 ALLSCHWIL, SWITZERLAND - 31 March 2017 - Johnson & Johnson (NYSE: JNJ) today...
Actelion lädt zur ordentlichen Generalversammlung 2017 ein
March 15, 2017 02:00 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SCHWEIZ - 15. März 2017 - Actelion Ltd (SIX: ATLN) veröffentlichte heute im Namen des Verwaltungsrats die offizielle Einladung zur diesjährigen ordentlichen Generalversammlung. Die...
Actelion issues invitation to 2017 Annual General Meeting of Shareholders
March 15, 2017 02:00 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SWITZERLAND - 15 March 2017 - Actelion Ltd (SIX: ATLN) today issued the formal invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of...
Actelion erhält Marktzulassung der Europäischen Kommission für Ledaga (Chlormethin-Gel) zur Behandlung von MF-CTCL
March 07, 2017 01:00 ET
|
Actelion Pharmaceuticals Ltd
ALLSCHWIL/BASEL, SCHWEIZ - 07. März 2017 - Actelion Ltd (SIX: ATLN) gab heute bekannt, dass die Europäische Kommission die Marktzulassung für den Einsatz von 160 Mikrogramm/g Ledaga®...